Soft-robotic Glove Support of High-demand Tasks
Primary Purpose
Neuromuscular Diseases, Sarcopenia
Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Soft robotic glove
Sponsored by
About this trial
This is an interventional other trial for Neuromuscular Diseases focused on measuring Soft-robotic glove, Wearable device, Hand function, Movement analysis
Eligibility Criteria
Inclusion Criteria:
Frail elderly with reduced hand function:
- Age between 65 and 90 years
- Experience difficulties in performing ADL due to a decline in hand function
- Able to make a pinch grip between thumb and middle or ring finger
- Sufficient cognitive status to understand two-step instructions
- Having (corrected to) normal vision
- Able to provide written informed consent
Neuromuscular patients:
- Age between 18 and 80 years
- Experience difficulties in performing ADL due to a decline in hand function that can be attributed to a diagnosed neuromuscular disease
- Being in a chronic and stable phase of disease
- Able to make a pinch grip between thumb and middle or ring finger
- Sufficient cognitive status to understand two-step instructions
- Having (corrected to) normal vision
- Able to provide written informed consent
Exclusion Criteria:
Frail elderly with reduced hand function:
- Currently receiving treatment for a disease affecting arm/hand function
- Used the CarbonHand system in the past 3 months
- Severe sensory problems of the most-affected hand
- Severe acute pain of the most-affected hand
- Wounds on the hands that can provide a problem when using the glove
- Severe contractures limiting passive range of motion
- Severe spasticity of the hand (≥2 points on Ashworth Scale)
- Insufficient knowledge of the Dutch language to understand the purpose or methods of the study
Neuromuscular patients:
- Severe sensory problems of the most-affected hand
Sites / Locations
- Roessingh Research and DevelopmentRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Study group
Arm Description
All participants in the study will perform arm/hand movement tasks in both of two conditions (with and without soft-robotic glove), so they constitute 1 study arm, but all receiving both intervention conditions (experimental - with glove and control - without glove).
Outcomes
Primary Outcome Measures
Kinematic movement profile during performance of strenuous ADL task
The kinematic movement profile during performance of strenuous ADL task, characterized by the following parameters as assessed using 3D marker-based motion capture: • Total movement duration
Duration of movement phases
Movement smoothness
Trunk displacement
Peak hand velocity
Time to peak velocity of reach phase
Hand opening
Joint excursion of the elbow
Joint excursion of the wrist
Endpoint straightness
Endpoint error
Secondary Outcome Measures
Experienced pain/discomfort rating + description
Discomfort and pain in the hand experienced by the participants will be assessed using a report form, indicating the amount of experienced pain and/or discomfort (using Visual Analogue Scales), and in case of discomfort or pain, a map of the hands to localize the pain/discomfort and a description of its sensation as well as an assumed cause. This will be done separately for each area in which discomfort and/or pain is reported.
Perceived exertion and confidence in grip rating
Perceived exertion/fatigue after the strenuous ADL tasks will be assessed using the Borg Rating Scale of Perceived Exertion. An additional question assesses the participants' confidence in their grip on the object as experienced during the ADL task performance.
Maximal handgrip strength
The maximal handgrip strength will be measured with a custom-made cylindrical dynamometer, recording the maximum force a person can exert on the dynamometer by forcefully gripping the cylinder. This will be done three times, if the last attempt is done with higher force than the second-to-last attempt, another attempt will be added, until the last value is lower than the second-to-last value.
Handgrip endurance
Handgrip endurance will also be measured with a custom-made cylindrical dynamometer. It will be measured in a static situation, by prolonged max contraction of hand grip during 30 seconds.
Number of repetitions achieved during ADL task
The number of repetitions achieved during execution of the ADL task (i.e., number of times the task was completed succesfully) in the four different conditions (no glove and unsupported max weight, no glove and supported max weight, glove and unsupported max weight, glove and supported max weight) will be recorded.
Muscle tissue oxygen saturation
The muscle oxygen saturation in the forearm is measured during the ADL task execution and handgrip strength and endurance tests using a NIRS sensor placed over the M. flexor radialis and ulnaris and the M. flexor digitorum superficialis, secured with Velcro straps around the forearm.
Amplitude, on/off times and median frequency of muscle activity
Muscle activity parameters will be calculated from surface EMG recordings of Abductor pollicis brevis, Extensor digitorum, Extensor carpi radialis, Extensor carpi ulnaris, Extensor pollicis brevis/longus, Flexor carpi ulnaris, Flexor carpi radialis
Full Information
NCT ID
NCT05318638
First Posted
December 21, 2021
Last Updated
September 4, 2023
Sponsor
Roessingh Research and Development
1. Study Identification
Unique Protocol Identification Number
NCT05318638
Brief Title
Soft-robotic Glove Support of High-demand Tasks
Official Title
Changes in Movement Profile Related to Use of a Soft-robotic Glove During High-demand Tasks
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 17, 2022 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Roessingh Research and Development
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The hand is important to perform activities of daily living (ADL). However, many people experience a loss of hand function as result of a traumatic brain injury, spinal cord injury, stroke or orthopedic problems, or due to ageing. To improve hand function, or reduce its decline, one can benefit from exercise therapy or use of assistive aids to improve ADL independence. A promising innovative approach combining both is a wearable soft-robotic glove that supports hand grip. With this glove, performance of functional activities can be supported directly, while also facilitating repeated use of the affected arm and hand during functional daily activities. One of our previous studies showed that besides a direct support effect, a therapeutic effect on performance was found after several weeks of using the soft-robotic glove as support during ADL. However, several participants reported complaints of increased pain and/or overload, mainly at the beginning of the trial. Clinicians suspect that a (too) high intensity of hand use compared to normal is contributing to this observation. This might be related to more fatigue experienced when using the glove in high-demand tasks, due to a larger movement capacity (faster, further, more repetitions) and can be associated with decreased blood perfusion/lower saturation levels at muscular level and altered muscle activation and movement coordination.
Therefore, the primary objective is to examine the effect of use of the assistive soft-robotic glove during strenuous ADL tasks on the kinematic movement profile, compared to not using the soft-robotic glove. Secondary objectives are to examine whether pain or discomfort is experienced in strenuous activities with the soft-robotic glove as well as the characteristics and locations of such pain/discomfort, and to examine whether use of the glove is associated with increased handgrip strength, larger number of ADL task repetitions, diminished blood perfusion / reduced tissue saturation at the muscle and/or changes in muscle activity.
Detailed Description
A promising innovative approach to improve hand function is to integrate exercise therapy with support of activities of daily life using an assistive device. This is possible using a wearable soft-robotic glove that supports hand grip. With this glove, performance of functional activities can be supported directly, while also facilitating repeated use of the affected arm and hand during functional daily activities. One of our previous studies showed that besides a direct support effect, a therapeutic effect on performance was found after several weeks of using the soft-robotic glove as support during ADL. However, several participants reported complaints of increased pain and/or overload, mainly at the beginning of the trial. Clinicians suspect that a (too) high intensity of hand use compared to normal is contributing to this observation. This might be related to more fatigue experienced when using the glove in high-demand tasks, due to a larger movement capacity (faster, further, more repetitions) and can be associated with decreased blood perfusion/lower saturation levels at muscular level and altered muscle activation and movement coordination.
The primary objective is to examine the effect of use of the assistive soft-robotic glove during strenuous ADL tasks on the kinematic movement profile, compared to not using the soft-robotic glove. Secondary objectives are to examine whether pain or discomfort is experienced in strenuous activities with the soft-robotic glove as well as the characteristics and locations of such pain/discomfort, and to examine whether use of the glove is associated with increased handgrip strength, larger number of ADL task repetitions, diminished blood perfusion / reduced tissue saturation at the muscle and/or changes in muscle activity.
The study is set-up as a cross-sectional intervention study with one measurement session, where participants will perform maximum handgrip strength tests and high-demand ADL-tasks with and without the soft-robotic glove. The aim is to include 20 participants in total, 10 of which will be frail elderly and the other 10 will be neuromuscular patients, all suffering from reduced hand function.
All participants will perform each movement task with and without the soft-robotic glove. The soft-robotic glove used in the study is the Carbonhand system (Bioservo Technologies, Sweden). It is a CE-marked medical device and it consists of a glove that supports finger flexion via sewn-in tendons and a control unit housing the actuators that pull on the tendons and the batteries. The grip support is activated by applying very light pressure on sensors in the fingertips of the glove, and de-activated by releasing the pressure on the sensors. After execution of all tasks with and without glove, differences in outcome measures will be compared between glove conditions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Diseases, Sarcopenia
Keywords
Soft-robotic glove, Wearable device, Hand function, Movement analysis
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The study is a cross-sectional intervention study with one measurement session, where participants will perform maximum handgrip strength tests and high-demand ADL-tasks with and without the soft-robotic glove (glove condition in randomized order).
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Study group
Arm Type
Other
Arm Description
All participants in the study will perform arm/hand movement tasks in both of two conditions (with and without soft-robotic glove), so they constitute 1 study arm, but all receiving both intervention conditions (experimental - with glove and control - without glove).
Intervention Type
Device
Intervention Name(s)
Soft robotic glove
Intervention Description
The soft-robotic glove used in the study is the Carbonhand system (Bioservo Technologies, Sweden). It is a CE-marked medical device and it consists of a glove that supports finger flexion via sewn-in tendons and a control unit housing the actuators that pull on the tendons and the batteries. The grip support is activated by applying very light pressure on sensors in the fingertips of the glove, and de-activated by releasing the pressure on the sensors.
Primary Outcome Measure Information:
Title
Kinematic movement profile during performance of strenuous ADL task
Description
The kinematic movement profile during performance of strenuous ADL task, characterized by the following parameters as assessed using 3D marker-based motion capture: • Total movement duration
Duration of movement phases
Movement smoothness
Trunk displacement
Peak hand velocity
Time to peak velocity of reach phase
Hand opening
Joint excursion of the elbow
Joint excursion of the wrist
Endpoint straightness
Endpoint error
Time Frame
1-2 hours during the measurement session
Secondary Outcome Measure Information:
Title
Experienced pain/discomfort rating + description
Description
Discomfort and pain in the hand experienced by the participants will be assessed using a report form, indicating the amount of experienced pain and/or discomfort (using Visual Analogue Scales), and in case of discomfort or pain, a map of the hands to localize the pain/discomfort and a description of its sensation as well as an assumed cause. This will be done separately for each area in which discomfort and/or pain is reported.
Time Frame
Twice during the measurement session, after completion of both conditions, with a duration of 5-10 minutes.
Title
Perceived exertion and confidence in grip rating
Description
Perceived exertion/fatigue after the strenuous ADL tasks will be assessed using the Borg Rating Scale of Perceived Exertion. An additional question assesses the participants' confidence in their grip on the object as experienced during the ADL task performance.
Time Frame
Twice during the measurement session, after completion of both conditions, with a duration of 5-10 minutes.
Title
Maximal handgrip strength
Description
The maximal handgrip strength will be measured with a custom-made cylindrical dynamometer, recording the maximum force a person can exert on the dynamometer by forcefully gripping the cylinder. This will be done three times, if the last attempt is done with higher force than the second-to-last attempt, another attempt will be added, until the last value is lower than the second-to-last value.
Time Frame
1-2 hours during the measurement session
Title
Handgrip endurance
Description
Handgrip endurance will also be measured with a custom-made cylindrical dynamometer. It will be measured in a static situation, by prolonged max contraction of hand grip during 30 seconds.
Time Frame
1-2 hours during the measurement session
Title
Number of repetitions achieved during ADL task
Description
The number of repetitions achieved during execution of the ADL task (i.e., number of times the task was completed succesfully) in the four different conditions (no glove and unsupported max weight, no glove and supported max weight, glove and unsupported max weight, glove and supported max weight) will be recorded.
Time Frame
1-2 hours during the measurement session
Title
Muscle tissue oxygen saturation
Description
The muscle oxygen saturation in the forearm is measured during the ADL task execution and handgrip strength and endurance tests using a NIRS sensor placed over the M. flexor radialis and ulnaris and the M. flexor digitorum superficialis, secured with Velcro straps around the forearm.
Time Frame
1-2 hours during the measurement session
Title
Amplitude, on/off times and median frequency of muscle activity
Description
Muscle activity parameters will be calculated from surface EMG recordings of Abductor pollicis brevis, Extensor digitorum, Extensor carpi radialis, Extensor carpi ulnaris, Extensor pollicis brevis/longus, Flexor carpi ulnaris, Flexor carpi radialis
Time Frame
1-2 hours during the measurement session
Other Pre-specified Outcome Measures:
Title
Subject characteristics
Description
Age
Sex
Most-affected side
Dominant side
Impairment/ disorder and date of diagnosis
Time Frame
At the start of the measurement session, taking about 5 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Frail elderly with reduced hand function:
Age between 65 and 90 years
Experience difficulties in performing ADL due to a decline in hand function
Able to make a pinch grip between thumb and middle or ring finger
Sufficient cognitive status to understand two-step instructions
Having (corrected to) normal vision
Able to provide written informed consent
Neuromuscular patients:
Age between 18 and 80 years
Experience difficulties in performing ADL due to a decline in hand function that can be attributed to a diagnosed neuromuscular disease
Being in a chronic and stable phase of disease
Able to make a pinch grip between thumb and middle or ring finger
Sufficient cognitive status to understand two-step instructions
Having (corrected to) normal vision
Able to provide written informed consent
Exclusion Criteria:
Frail elderly with reduced hand function:
Currently receiving treatment for a disease affecting arm/hand function
Used the CarbonHand system in the past 3 months
Severe sensory problems of the most-affected hand
Severe acute pain of the most-affected hand
Wounds on the hands that can provide a problem when using the glove
Severe contractures limiting passive range of motion
Severe spasticity of the hand (≥2 points on Ashworth Scale)
Insufficient knowledge of the Dutch language to understand the purpose or methods of the study
Neuromuscular patients:
Severe sensory problems of the most-affected hand
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
G. Prange, PhD
Phone
+31 88875777
Email
g.prange@rrd.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
G. Prange, PhD
Organizational Affiliation
Roessingh Research and Development
Official's Role
Principal Investigator
Facility Information:
Facility Name
Roessingh Research and Development
City
Enschede
State/Province
Overijssel
ZIP/Postal Code
7522AH
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
G. Prange, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Soft-robotic Glove Support of High-demand Tasks
We'll reach out to this number within 24 hrs